140 related articles for article (PubMed ID: 28132916)
21. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently.
Turcatti G; Vogel H; Chollet A
Biochemistry; 1995 Mar; 34(12):3972-80. PubMed ID: 7696262
[TBL] [Abstract][Full Text] [Related]
22. NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors.
Giuliani D; Neri L; Canalini F; Calevro A; Ottani A; Vandini E; Sena P; Zaffe D; Guarini S
Mol Cell Neurosci; 2015 Jul; 67():13-21. PubMed ID: 26003413
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.
Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ
J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518
[TBL] [Abstract][Full Text] [Related]
24. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
25. Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions.
De Silva CR; Vagner J; Lynch R; Gillies RJ; Hruby VJ
Anal Biochem; 2010 Mar; 398(1):15-23. PubMed ID: 19852924
[TBL] [Abstract][Full Text] [Related]
26. Dimerization of the melanocortin 4 receptor: a study using bioluminescence resonance energy transfer.
Nickolls SA; Maki RA
Peptides; 2006 Feb; 27(2):380-7. PubMed ID: 16406142
[TBL] [Abstract][Full Text] [Related]
27. Use of fluorescence polarization detection for the measurement of fluopeptidetm binding to G protein-coupled receptors.
Gagne A; Banks P; Hurt SD
J Recept Signal Transduct Res; 2002; 22(1-4):333-43. PubMed ID: 12503625
[TBL] [Abstract][Full Text] [Related]
28. Assays with Detection of Fluorescence Anisotropy: Challenges and Possibilities for Characterizing Ligand Binding to GPCRs.
Rinken A; Lavogina D; Kopanchuk S
Trends Pharmacol Sci; 2018 Feb; 39(2):187-199. PubMed ID: 29102621
[TBL] [Abstract][Full Text] [Related]
29. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
30. Structure and function of the potent cyclic and linear melanocortin analogues.
Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel melanocortin4 receptor selective MSH analogues.
Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
33. Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling.
Spencer JD; Schallreuter KU
Endocrinology; 2009 Mar; 150(3):1250-8. PubMed ID: 18974267
[TBL] [Abstract][Full Text] [Related]
34. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.
Fleck BA; Chen C; Yang W; Huntley R; Markison S; Nickolls SA; Foster AC; Hoare SR
Biochemistry; 2005 Nov; 44(44):14494-508. PubMed ID: 16262250
[TBL] [Abstract][Full Text] [Related]
35. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction.
Chen M; Aprahamian CJ; Celik A; Georgeson KE; Garvey WT; Harmon CM; Yang Y
Biochemistry; 2006 Jan; 45(4):1128-37. PubMed ID: 16430209
[TBL] [Abstract][Full Text] [Related]
37. Development of a homogeneous high throughput fluorescence polarization assay for G protein-coupled receptor binding.
Lee PH; Bevis DJ
J Biomol Screen; 2000 Dec; 5(6):415-19. PubMed ID: 11598459
[TBL] [Abstract][Full Text] [Related]
38. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.
Giuliani D; Mioni C; Bazzani C; Zaffe D; Botticelli AR; Capolongo S; Sabba A; Galantucci M; Iannone A; Grieco P; Novellino E; Colombo G; Tomasi A; Catania A; Guarini S
Br J Pharmacol; 2007 Mar; 150(5):595-603. PubMed ID: 17245369
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
40. Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor.
Sklar LA; Sayre J; McNeil VM; Finney DA
Mol Pharmacol; 1985 Oct; 28(4):323-30. PubMed ID: 4058418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
